ITEM METADATA RECORD
Title: Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?
Authors: De Bock, Katrien
Mazzone, Max
Carmeliet, Peter # ×
Issue Date: 2011
Publisher: Nature Publishing Group
Series Title: Nature Reviews. Clinical Oncology vol:8 issue:7 pages:393-404
Article number: 10.1038/nrclinonc.2011.83
Abstract: All human cells, including cancer cells, need oxygen and nutrients to survive. A widely used strategy to combat cancer is therefore the starvation of tumor cells by cutting off the blood supply of tumors. Clinical experience indeed shows that tumor progression can be delayed by anti-angiogenic agents. However, emerging evidence indicates that in certain experimental conditions, hypoxia as a result of pruning of the tumor microvasculature can promote tumor invasion and metastasis, although these findings are contextual and debated. Genetic studies in mice unveiled that vascular-targeting strategies that avoid aggravation of tumor hypoxia or even promote tumor oxygenation might prevent such an invasive metastatic switch. In this article, we will discuss the emerging link between hypoxia signaling and the various steps of metastasis.
URI: 
ISSN: 1759-4774
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Vesalius Research Centre (-)
Laboratory of Tumor Inflammation and Angiogenesis (Vesalius Research Center) (+)
Laboratory of Angiogenesis and Vascular Metabolism (Vesalius Research Center) (+)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
De Bock_Antiangiogenic therapy hypoxia and metastasis risky liaisons or not?_Nat Rev Clin Oncol2011.pdf Published 652KbAdobe PDFView/Open

 


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science